Oct 23 (Reuters) - AstraZeneca PLC:

* FDA AUTHORISES RESTART OF COVID-19 AZD1222 VACCINE US PHASE III TRIA

* FOOD AND DRUG ADMINISTRATION (FDA) AUTHORISED RESTART OF TRIAL IN US

* FDA REVIEWED ALL SAFETY DATA FROM TRIALS GLOBALLY AND CONCLUDED IT WAS SAFE TO RESUME TRIAL. Further company coverage: